Literature DB >> 26008608

Osteoclast fusion is initiated by a small subset of RANKL-stimulated monocyte progenitors, which can fuse to RANKL-unstimulated progenitors.

Noam Levaot1, Aner Ottolenghi2, Mati Mann3, Gali Guterman-Ram2, Zvi Kam4, Benjamin Geiger5.   

Abstract

Osteoclasts are multinucleated, bone-resorbing cells formed via fusion of monocyte progenitors, a process triggered by prolonged stimulation with RANKL, the osteoclast master regulator cytokine. Monocyte fusion into osteoclasts has been shown to play a key role in bone remodeling and homeostasis; therefore, aberrant fusion may be involved in a variety of bone diseases. Indeed, research in the last decade has led to the discovery of genes regulating osteoclast fusion; yet the basic cellular regulatory mechanism underlying the fusion process is poorly understood. Here, we applied a novel approach for tracking the fusion processes, using live-cell imaging of RANKL-stimulated and non-stimulated progenitor monocytes differentially expressing dsRED or GFP, respectively. We show that osteoclast fusion is initiated by a small (~2.4%) subset of precursors, termed "fusion founders", capable of fusing either with other founders or with non-stimulated progenitors (fusion followers), which alone, are unable to initiate fusion. Careful examination indicates that the fusion between a founder and a follower cell consists of two distinct phases: an initial pairing of the two cells, typically lasting 5-35 min, during which the cells nevertheless maintain their initial morphology; and the fusion event itself. Interestingly, during the initial pre-fusion phase, a transfer of the fluorescent reporter proteins from nucleus to nucleus was noticed, suggesting crosstalk between the founder and follower progenitors via the cytoplasm that might directly affect the fusion process, as well as overall transcriptional regulation in the developing heterokaryon.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell biology; Differentiation; Fusion; Osteoclast; Progenitors

Mesh:

Substances:

Year:  2015        PMID: 26008608     DOI: 10.1016/j.bone.2015.05.021

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  19 in total

1.  Cell-surface phosphatidylserine regulates osteoclast precursor fusion.

Authors:  Santosh K Verma; Evgenia Leikina; Kamran Melikov; Claudia Gebert; Vardit Kram; Marian F Young; Berna Uygur; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2017-11-03       Impact factor: 5.157

2.  Suppression of Notch Signaling in Osteoclasts Improves Bone Regeneration and Healing.

Authors:  Peeyush N Goel; Yasaman Moharrer; John H Hebb; Alexander J Egol; Gurpreet Kaur; Kurt D Hankenson; Jaimo Ahn; Jason W Ashley
Journal:  J Orthop Res       Date:  2019-06-24       Impact factor: 3.494

3.  An SNX10-dependent mechanism downregulates fusion between mature osteoclasts.

Authors:  Maayan Barnea-Zohar; Sabina E Winograd-Katz; Moran Shalev; Esther Arman; Nina Reuven; Lee Roth; Ofra Golani; Merle Stein; Fadi Thalji; Moien Kanaan; Jan Tuckermann; Benjamin Geiger; Ari Elson
Journal:  J Cell Sci       Date:  2021-05-11       Impact factor: 5.285

4.  Integrated computational and in vivo models reveal Key Insights into macrophage behavior during bone healing.

Authors:  Etienne Baratchart; Chen Hao Lo; Conor C Lynch; David Basanta
Journal:  PLoS Comput Biol       Date:  2022-05-13       Impact factor: 4.779

Review 5.  Gold Nanomaterials and Bone/Cartilage Tissue Engineering: Biomedical Applications and Molecular Mechanisms.

Authors:  Yifeng Shi; Xuyao Han; Shuang Pan; Yuhao Wu; Yuhan Jiang; Jinghao Lin; Yihuang Chen; Haiming Jin
Journal:  Front Chem       Date:  2021-07-09       Impact factor: 5.221

6.  Monitoring Cell Proliferation by Dye Dilution: Considerations for Probe Selection.

Authors:  Joseph D Tario; Alexis N Conway; Katharine A Muirhead; Paul K Wallace
Journal:  Methods Mol Biol       Date:  2018

7.  Resveratrol prevents osteoporosis by upregulating FoxO1 transcriptional activity.

Authors:  Yan-Ling Feng; Xiao-Tong Jiang; Fang-Fang Ma; Jie Han; Xu-Lei Tang
Journal:  Int J Mol Med       Date:  2017-10-23       Impact factor: 4.101

8.  An improved metrics for osteoclast multinucleation.

Authors:  Santosh K Verma; Leonid V Chernomordik; Kamran Melikov
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

9.  Erythropoietin receptor in B cells plays a role in bone remodeling in mice.

Authors:  Naamit Deshet-Unger; Albert Kolomansky; Nathalie Ben-Califa; Sahar Hiram-Bab; Dafna Gilboa; Tamar Liron; Maria Ibrahim; Zamzam Awida; Anton Gorodov; Howard S Oster; Moshe Mittelman; Martina Rauner; Ben Wielockx; Yankel Gabet; Drorit Neumann
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

Review 10.  Osteoclast Multinucleation: Review of Current Literature.

Authors:  Joe Kodama; Takashi Kaito
Journal:  Int J Mol Sci       Date:  2020-08-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.